Predictive factors of pathological vascular invasion in hepatocellular carcinoma within 3 cm and three nodules without radiological vascular invasion

Hepatology Research

Volumn 46, Issue 10, 2016, Pages 985-991

  Masuda, Toshiro ^a,b   Beppu, Toru ^a   Okabe, Hirohisa ^a   Nitta, Hidetoshi ^a   Imai, Katsunori ^a   Hayashi, Hiromitsu ^a   Chikamoto, Akira ^a   Yamamoto, Kenichiro ^b   Ikeshima, Satoshi ^b   Kuramoto, Masafumi ^b   Shimada, Shinya ^b   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KYUSHU HOSPITAL   (Japan)

Author keywords

ablation therapy; hepatocellular carcinoma; pathological vascular invasion

Indexed keywords

ALPHA FETOPROTEIN;

AGED; ARTICLE; CANCER SURVIVAL; COMMON HEPATIC DUCT; CONTROLLED STUDY; FEMALE; HEPATIC ARTERY; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER VEIN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTION; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; TUMOR INVASION; TUMOR VOLUME; TUMPR VASCULAR INVASION;

EID: 84985972822     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12637     Document Type: Article

References (39)

1. Burroughs A, Hochhauser D, Meyer T. Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum. Lancet Oncol 2004; Jul; 5: 409–18.
2. Au JS, Frenette CT. Management of Hepatocellular Carcinoma: Current Status and Future Directions. Gut Liver 2015; Jul 23;9: 437–48.
3. Attwa MH, El-Etreby SA. Guide for diagnosis and treatment of hepatocellular carcinoma. World J Hepatol 2015; Jun 28; 7: 1632–51.
4. Tiong L, Maddern GJ. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2011; Sep; 98: 1210–24.
5. Livraghi T, Meloni F, Di Stasi M et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 2008; Jan; 47: 82–9.
6. Arii S, Yamaoka Y, Futagawa S et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000; Dec; 32: 1224–9.
7. Chen MS, Li JQ, Zheng Y et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006; Mar; 243: 321–8.
8. Huang J, Yan L, Cheng Z et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 2010; Dec; 252: 903–12.
9. Hasegawa K, Makuuchi M, Takayama T et al. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol 2008; Oct; 49: 589–94.
10. Takayama T, Makuuchi M, Hasegawa K. Single HCC smaller than 2 cm: surgery or ablation?: surgeon's perspective. J Hepatobiliary Pancreat Sci 2010; Jul; 17: 422–4.
11. Murakami T, Ishimaru H, Sakamoto I et al. Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence. Cardiovasc Intervent Radiol 2007; Jul-Aug; 30: 696–704.
12. Roayaie S, Obeidat K, Sposito C et al. Resection of hepatocellular cancer
13. Nakashima Y, Nakashima O, Tanaka M, Okuda K, Nakashima M, Kojiro M. Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. Hepatol Res. 2003; Jun; 26: 142–7.
14. Masuda T, Beppu T, Ishiko T et al. Intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy. J Hepatobiliary Pancreat Surg 2008; 15: 589–95.
15. Ariizumi S, Kitagawa K, Kotera Y et al. A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 2011; Jul; 18: 575–85.
16. Okabe H, Beppu T, Chikamoto A et al. Remnant liver volume-based predictors of postoperative liver dysfunction after hepatectomy: analysis of 625 consecutive patients from a single institution. Int J Clin Oncol 2014; Aug; 19: 614–21.
17. Hayashi H, Beppu T, Okabe H et al. Functional assessment versus conventional volumetric assessment in the prediction of operative outcomes after major hepatectomy. Surgery 2015; Jan; 157: 20–6.
18. Asaoka Y, Tateishi R, Nakagomi R et al. Frequency of and predictive factors for vascular invasion after radiofrequency ablation for hepatocellular carcinoma. PLoS One 2014; 9: e111662.
19. Yamashita Y, Tsuijita E, Takeishi K et al. Predictors for microinvasion of small hepatocellular carcinoma
20. Dong W, Zhang T, Wang ZG, Liu H. Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysis. World J Gastroenterol 2014; Aug 7; 20: 10174–82.
21. Masuda T, Beppu T, Ishiko T et al. Thermal Ablation Using Microwave Coagulation Therapy (MCT) and Radiofrequency Ablation (RFA) for Hepatocellular Carcinoma. Theor Med 2007; 23: 123–31.
22. Lencioni R, Cioni D, Crocetti L et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; Mar; 234: 961–7.
23. Peng ZW, Lin XJ, Zhang YJ et al. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study. Radiology 2012; Mar; 262: 1022–33.
24. Okusaka T, Okada S, Ueno H et al. Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features. Cancer 2002; Nov 1; 95: 1931–7.
25. Iida H, Aihara T, Ikuta S, Yamanaka N. Comparative study of percutaneous radiofrequency ablation and hepatic resection for small, poorly differentiated hepatocellular carcinomas. Hepatol Res 2014; Oct; 44: E156–62.
26. Imai K, Beppu T, Nakayama Y et al. Preoperative prediction of poorly differentiated components in small-sized hepatocellular carcinoma for safe local ablation therapy. J Surg Oncol 2009; Aug 1; 100: 121–6.
27. Imai K, Beppu T, Chikamoto A et al. Comparison between hepatic resection and radiofrequency ablation as first-line treatment for solitary small-sized hepatocellular carcinoma of 3 cm or less. Hepatol Res 2013; 43: 853–64.
28. Nakagawa S, Beppu T, Okabe H et al. Triple positive tumor markers predict recurrence and survival in early stage hepatocellular carcinoma. Hepatol Res 2014; Sep; 44: 964–74.
29. Toyoda H, Kumada T, Kiriyama S et al. Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma. Clin Gastroenterol Hepatol 2006; Jan; 4: 111–7.
30. Koike Y, Shiratori Y, Sato S et al. Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients. Cancer 2001; Feb 1; 91: 561–9.
31. Pote N, Cauchy F, Albuquerque M et al. Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion. J Hepatol 2015; Apr; 62: 848–54.
32. Hatanaka K, Minami Y, Kudo M, Inoue T, Chung H, Haji S. The gross classification of hepatocellular carcinoma: usefulness of contrast-enhanced US. J Clin Ultrasound 2014; Jan; 42: 1–8.
33. Tada T, Kumada T, Toyoda H et al. Diagnostic accuracy for macroscopic classification of nodular hepatocellular carcinoma: comparison of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and angiography-assisted computed tomography. J Gastroenterol 2015; Jan; 50: 85–94.
34. Zhao WC, Fan LF, Yang N, Zhang HB, Chen BD, Yang GS. Preoperative predictors of microvascular invasion in multinodular hepatocellular carcinoma. Eur J Surg Oncol 2013; Aug; 39: 858–64.
35. You Z, Chen LP, Ye H. Predictors of microvascular invasion in patients with solitary small hepatitis B related hepatocellular carcinoma. Pak J Med Sci 2014; Mar; 30: 331–4.
36. Kim JM, Kang TW, Kwon CH et al. Single hepatocellular carcinoma
37. Lim KC, Chow PK, Allen JC et al. Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria. Ann Surg 2011; Jul; 254: 108–13.
38. Yuan SX, Yang F, Yang Y et al. Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy. Hepatology 2012; Dec; 56: 2231–41.
39. Shindoh J, Andreou A, Aloia TA et al. Microvascular invasion does not predict long-term survival in hepatocellular carcinoma up to 2 cm: reappraisal of the staging system for solitary tumors. Ann Surg Oncol 2013; Apr; 20: 1223–9.